Liver disease in pregnancy

World Journal of Gastroenterology

Volumn 15, Issue 8, 2009, Pages 897-906

  Lee, Noel M ^a   Brady, Carla W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cesarean section; Cholestasis; Fetal outcome; Liver disease; Maternal outcome; Pregnancy; Viral hepatitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLESTYRAMINE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; LAMIVUDINE; MAGNESIUM SULFATE; METOCLOPRAMIDE; OCTREOTIDE; ONDANSETRON; PEGINTERFERON; PENICILLAMINE; PROCHLORPERAZINE; PROMETHAZINE; RIBAVIRIN; S ADENOSYLMETHIONINE; STEROID; TRIENTINE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VASOPRESSIN; VITAMIN K GROUP; ZINC;

ACUTE FATTY LIVER OF PREGNANCY; AUTOIMMUNE HEPATITIS; BREAST FEEDING; CHOLECYSTECTOMY; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL MALFORMATION; ECLAMPSIA; EDITORIAL; EMBRYOTOXICITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FETUS MORTALITY; GALLSTONE; HELLP SYNDROME; HEPATITIS B; HEPATITIS C; HUMAN; HYPEREMESIS GRAVIDARUM; INFECTION PREVENTION; INTRAHEPATIC CHOLESTASIS; LABOR INDUCTION; LIVER CIRRHOSIS; LIVER DISEASE; LOW BIRTH WEIGHT; LOW DRUG DOSE; MALABSORPTION; MATERNAL MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRURITUS; RESPIRATION DEPRESSION; SMALL FOR DATE INFANT; TERATOGENICITY; VERTICAL TRANSMISSION; WILSON DISEASE; CHOLESTASIS; FATTY LIVER; FEMALE; PREGNANCY COMPLICATION; REVIEW;

CHOLESTASIS; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 65649083685     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.897     Document Type: Editorial

References (103)

1. Fairweather DV. Nausea and vomiting in pregnancy. Am J Obstet Gynecol 1968; 102: 135-175
2. Kallen B. Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol 1987; 26: 291-302
3. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 1993; 43: 245-248
4. Goodwin TM, Hershman JM, Cole L. Increased concentration of the free beta-subunit of human chorionic gonadotropin in hyperemesis gravidarum. Acta Obstet Gynecol Scand 1994; 73: 770-772
5. Panesar NS, Li CY, Rogers MS. Are thyroid hormones or hCG responsible for hyperemesis gravidarum? A matched paired study in pregnant Chinese women. Acta Obstet Gynecol Scand 2001; 80: 519-524
6. Taskin S, Taskin EA, Seval MM, Atabekoglu CS, Berker B, Soylemez F. Serum levels of adenosine deaminase and pregnancy-related hormones in hyperemesis gravidarum. J Perinat Med 2009; 37: 32-35
7. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005; 11: 527-539
8. Kaplan PB, Gucer F, Sayin NC, Yuksel M, Yuce MA, Yardim T. Maternal serum cytokine levels in women with hyperemesis gravidarum in the first trimester of pregnancy. Fertil Steril 2003; 79: 498-502
9. Leylek OA, Toyaksi M, Erselcan T, Dokmetas S. Immunologic and biochemical factors in hyperemesis gravidarum with or without hyperthyroxinemia. Gynecol Obstet Invest 1999; 47: 229-234
10. Minagawa M, Narita J, Tada T, Maruyama S, Shimizu T, Bannai M, Oya H, Hatakeyama K, Abo T. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell Immunol 1999; 196: 1-13
11. Hepburn IS, Schade RR. Pregnancy-associated liver disorders. Dig Dis Sci 2008; 53: 2334-2358
12. Conchillo JM, Pijnenborg JM, Peeters P, Stockbrugger RW, Fevery J, Koek GH. Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment. Neth J Med 2002; 60: 374-378
13. Tsang IS, Katz VL, Wells SD. Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynaecol Obstet 1996; 55: 231-235
14. Bailit JL. Hyperemesis gravidarium: Epidemiologic findings from a large cohort. Am J Obstet Gynecol 2005; 193: 811-814
15. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799
16. Thadhani R, Solomon CG. Preeclampsia - a glimpse into the future? N Engl J Med 2008; 359: 858-860
17. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med 1996; 335: 569-576
18. Dani R, Mendes GS, Medeiros Jde L, Peret FJ, Nunes A. Study of the liver changes occurring in preeclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. Am J Gastroenterol 1996; 91: 292-294
19. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000-1006
20. Martin JN Jr, Blake PG, Perry KG Jr, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164: 1500-1509; discussion 1509-1513
21. Hupuczi P, Nagy B, Sziller I, Rigo B, Hruby E, Papp Z. Characteristic laboratory changes in pregnancies complicated by HELLP syndrome. Hypertens Pregnancy 2007; 26: 389-401
22. Castro MA, Fassett MJ, Reynolds TB, Shaw KJ, Goodwin TM. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999; 181: 389-395
23. Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006; 12: 7397-7404
24. Bacq Y. Acute fatty liver of pregnancy. Semin Perinatol 1998; 22: 134-140
25. Usta IM, Barton JR, Amon EA, Gonzalez A, Sibai BM. Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol 1994; 171: 1342-1347
26. Castro MA, Ouzounian JG, Colletti PM, Shaw KJ, Stein SM, Goodwin TM. Radiologic studies in acute fatty liver of pregnancy. A review of the literature and 19 new cases. J Reprod Med 1996; 41: 839-843
27. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology 1990; 11: 59-64
28. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997; 12: 211-216
29. Tan LK. Obstetric cholestasis: current opinions and management. Ann Acad Med Singapore 2003; 32: 294-298
30. Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210-211
31. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 1012-1021
32. Rodrigues CM, Marin JJ, Brites D. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Gut 1999; 45: 446-452
33. Sepulveda WH, Gonzalez C, Cruz MA, Rudolph MI. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol 1991; 42: 211-215
34. Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes GL, Glasinovic JC. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 2003; 189: 577-582
35. Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol 2008; 14: 5781-5788
36. Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomaki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006; 43: 723-728
37. Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 318-328
38. Serrano MA, Brites D, Larena MG, Monte MJ, Bravo MP, Oliveira N, Marin JJ. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 1998; 28: 829-839
39. Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005; 129: 894-901
40. Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, Ghidini A. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-1-methionine in the treatment of gestational cholestasis. BJOG 2004; 111: 17-21
41. Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399-1405
42. Gilat T, Konikoff F. Pregnancy and the biliary tract. Can J Gastroenterol 2000; 14 Suppl D: 55D-59D
43. Everson GT. Gallbladder function in gallstone disease. Gastroenterol Clin North Am 1991; 20: 85-110
44. Kapicioglu S, Gurbuz S, Danalioglu A, Senturk O, Uslu M. Measurement of gallbladder volume with ultrasonography in pregnant women. Can J Gastroenterol 2000; 14: 403-405
45. Ko CW, Beresford SA, Schulte SJ, Matsumoto AM, Lee SP. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 2005; 41: 359-365
46. Ko CW, Beresford SA, Schulte SJ, Lee SP. Insulin resistance and incident gallbladder disease in pregnancy. Clin Gastroenterol Hepatol 2008; 6: 76-81
47. Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy. Am J Surg 1994; 168: 576-579; discussion 580-581
48. Lu EJ, Curet MJ, El-Sayed YY, Kirkwood KS. Medical versus surgical management of biliary tract disease in pregnancy. Am J Surg 2004; 188: 755-759
49. Graham G, Baxi L, Tharakan T. Laparoscopic cholecystectomy during pregnancy: a case series and review of the literature. Obstet Gynecol Surv 1998; 53: 566-574
50. Tham TC, Vandervoort J, Wong RC, Montes H, Roston AD, Slivka A, Ferrari AP, Lichtenstein DR, Van Dam J, Nawfel RD, Soetikno R, Carr-Locke DL. Safety of ERCP during pregnancy. Am J Gastroenterol 2003; 98: 308-311
51. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-1580
52. Goh SK, Gull SE, Alexander GJ. Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature. BJOG 2001; 108: 760-762
53. Ahrens EH Jr, Payne MA, Kunkel HG, Eisenmenger WJ, Blondheim SH. Primary biliary cirrhosis. Medicine (Baltimore) 1950; 29: 299-364
54. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973; 289: 674-678
55. Whelton MJ, Sherlock S. Pregnancy in patients with hepatic cirrhosis. Management and outcome. Lancet 1968; 2: 995-999
56. Poupon R, Chretien Y, Chazouilleres O, Poupon RE. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol 2005; 42: 418-419
57. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-933
58. Landon MB, Soloway RD, Freedman LJ, Gabbe SG. Primary sclerosing cholangitis and pregnancy. Obstet Gynecol 1987; 69: 457-460
59. Christensen KL, Andersen BN, Vilstrup H. [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid] Ugeskr Laeger 1997; 159: 7151-7153
60. Janczewska I, Olsson R, Hultcrantz R, Broome U. Pregnancy in patients with primary sclerosing cholangitis. Liver 1996; 16: 326-330
61. Gossard AA, Lindor KD. Pregnancy in a patient with primary sclerosing cholangitis. J Clin Gastroenterol 2002; 35: 353-355
62. Candia L, Marquez J, Espinoza LR. Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma. Semin Arthritis Rheum 2005; 35: 49-56
63. Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006; 101: 556-560
64. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999; 283: 1277-1278
65. Rosenkrantz JG, Githens JH, Cox SM, Kellum DL. Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol 1967; 97: 387-394
66. Tuchmann-Duplessis H, Mercier-Parot L. [Production in rabbits of malformations of the extremities by administration of azathioprine and 6-mercaptopurine] C R Seances Soc Biol Fil 1966; 160: 501-506
67. Saarikoski S, Seppala M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973; 115: 1100-1106
68. Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001; 48: 97-102
69. Ferenci P. Wilson's disease. Clin Liver Dis 1998; 2: 31-49, v-vi
70. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007; 369: 397-408
71. Sternlieb I. Wilson's disease and pregnancy. Hepatology 2000; 31: 531-532
72. Scheinberg IH, Sternlieb I. Pregnancy in penicillamine-treated patients with Wilson's disease. N Engl J Med 1975; 293: 1300-1302
73. Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Swamy HS. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease. J Neurol Sci 2004; 217: 37-40
74. Keen CL, Mark-Savage P, Lonnerdal B, Hurley LS. Teratogenic effects of D-penicillamine in rats: relation to copper deficiency. Drug Nutr Interact 1983; 2: 17-34
75. Mjolnerod OK, Dommerud SA, Rasmussen K, Gjeruldsen ST. Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet 1971; 1: 673-675
76. Solomon L, Abrams G, Dinner M, Berman L. Neonatal abnormalities associated with D-penicillamine treatment during pregnancy. N Engl J Med 1977; 296: 54-55
77. Rosa FW. Teratogen update: penicillamine. Teratology 1986; 33: 127-131
78. Walshe JM. Pregnancy in Wilson's disease. Q J Med 1977; 46: 73-83
79. Keen CL, Cohen NL, Lonnerdal B, Hurley LS. Teratogenesis and low copper status resulting from triethylenetetramine in rats. Proc Soc Exp Biol Med 1983; 173: 598-605
80. Brewer GJ, Johnson VD, Dick RD, Hedera P, Fink JK, Kluin KJ. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. Hepatology 2000; 31: 364-370
81. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745
82. Chang MH. Chronic hepatitis virus infection in children. J Gastroenterol Hepatol 1998; 13: 541-548
83. Shapiro CN. Epidemiology of hepatitis B. Pediatr Infect Dis J 1993; 12: 433-437
84. Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994; 44: 144-151
85. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004; 351: 2832-2838
86. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States [Centers for Disease Control and Prevention website]. Available at: http://www.cdc.gov/mmwr/ preview/mmwrhtml/rr5416a1.htm?s_cid=rr5416a1_e. Accessed September 17, 2008
87. Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events - United States, 2008 [Centers for Disease Control and Prevention website]. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ rr5706a1.htm. Accessed September 17, 2008
88. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10: 294-297
89. van Nunen AB, de Man RA, Heijtink RA, Niesters HG, Schalm SW. Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J Hepatol 2000; 32: 1040-1041
90. Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, Eidelman AI. Breastfeeding and the use of human milk. Pediatrics 2005; 115: 496-506
91. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31: 751-755
92. Pergam SA, Wang CC, Gardella CM, Sandison TG, Phipps WT, Hawes SE. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 2008; 199: 38.e1-38.e9
93. Jabeen T, Cannon B, Hogan J, Crowley M, Devereux C, Fanning L, Kenny-Walsh E, Shanahan F, Whelton MJ. Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM 2000; 93: 597-601
94. Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, Alter MJ. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192: 1880-1889
95. Hepatitis B and C Infections [Centers for Disease Control and Prevention website]. Available at: http://www.cdc.gov/breastfeeding/disease/ hepatitis.htm. Accessed on September 10, 2008
96. Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med 2000; 28: 372-376
97. Trotter JF, Zygmunt AJ. Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C. J Clin Gastroenterol 2001; 32: 76-78
98. Ruggiero G, Andreana A, Zampino R. Normal pregnancy under inadvertent alpha-interferon therapy for chronic hepatitis C. J Hepatol 1996; 24: 646
99. Yip DM, Baker AL. Liver diseases in pregnancy. Clin Perinatol 1985; 12: 683-694
100. Cheng YS. Pregnancy in liver cirrhosis and/or portal hypertension. Am J Obstet Gynecol 1977; 128: 812-822
101. Hay JE. Liver disease in pregnancy. Hepatology 2008; 47: 1067-1076
102. Russell MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol 1998; 22: 156-165
103. Britton RC. Pregnancy and esophageal varices. Am J Surg 1982; 143: 421-425